公司资料

Alphatec Holdings, Inc. 股价、新闻与催化剂

股票代码:
ATEC
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

9.45 USD (-3.47%)

收盘价

最后更新: 2026年8月17日

1.15B USD

市值

股价为何变动

As of Aug 17, 2026, ATEC closed down 3.47% at $9.45. No new same-company headline was identified in the current news window.

公司概览

业务概览

Alphatec is a spine-focused medical device company with a growing portfolio of procedural and reconstructive products.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Alphatec sits in procedure-driven medtech.

商业模式特征

Its revenue is driven by surgical adoption, product launches, and the expansion of its spine franchise.

生物医药行业定位

Alphatec is a growth-oriented medtech name that trades on procedural adoption and operating execution.

未来催化剂

  • Alphatec's catalysts are spine-procedure growth, EOS / surgical-platform adoption, and continued surgeon penetration. The company matters most when product-cycle execution turns into repeatable procedure share.

近期新闻

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

    ATEC Welcomes EOS Imaging Team

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。